Insider Trading activities of Neopharm Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Neopharm Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Neopharm Inc since year 2005. Table 2 shows the detailed insider transactions of Neopharm Inc since 2005. The reporting company's ticker symbol is NEOL. The reporting company's CIK number is 942788.
The total value of stock buying since 2005 is $3,882,610.
The total value of stock sales since 2005 is $60,029.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Neopharm Inc (NEOL).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2009-03 286,901 $16,417 0 $0 0 $0
2008-06 85,000 $60,275 0 $0 0 $0
2008-05 54,000 $32,067 0 $0 0 $0
2007-11 0 $0 33,000 $29,073 0 $0
2007-05 0 $0 21,276 $30,956 0 $0
2006-10 52,000 $329,408 0 $0 0 $0
2006-09 42,000 $206,920 0 $0 0 $0
2006-08 3,882 $19,561 0 $0 0 $0
2006-06 40,000 $200,000 0 $0 0 $0
2006-01 204,900 $2,089,979 0 $0 0 $0
2005-09 28,000 $333,480 0 $0 0 $0
2005-03 73,054 $594,503 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Neopharm Inc insiders (NEOL)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2009-03-13 Kapoor John N (Chairman of the Board) Buy 25,000 .07 1,750
2009-03-12 Birch Laurence (President, CEO and CFO) Buy 25,000 .04 1,050
2009-03-12 Kapoor John N (Chairman of the Board) Buy 203,000 .06 12,180
2009-03-11 Birch Laurence (President, CEO and CFO) Buy 11,901 .04 535
2009-03-11 Kapoor John N (Chairman of the Board) Buy 22,000 .04 902
2008-06-05 Kapoor John N (Chairman of the Board) Buy 11,500 .83 9,591
2008-06-04 Kapoor John N (Chairman of the Board) Buy 25,000 .72 17,975
2008-06-03 Kapoor John N (Chairman of the Board) Buy 20,000 .68 13,700
2008-06-02 Kapoor John N (Chairman of the Board) Buy 28,500 .67 19,009
2008-05-30 Fox Bernard A (Director) Buy 4,000 .61 2,440
2008-05-30 Kapoor John N (Chairman of the Board) Buy 9,600 .61 5,894
2008-05-29 Kapoor John N (Chairman of the Board) Buy 400 .58 233
2008-05-28 Kapoor John N (Chairman of the Board) Buy 30,000 .59 17,610
2008-05-27 Birch Laurence (President, CEO and CFO) Buy 10,000 .59 5,890
2007-11-15 Becker Frank C (Director) Sale 33,000 .88 29,073
2007-05-24 Hanson Erick E (Director) Sale 21,276 1.46 30,956
2006-10-16 Kapoor John N (Chairman of the Board) Buy 5,000 7.94 39,680
2006-10-13 Kapoor John N (Chairman of the Board) Buy 5,000 7.48 37,395
2006-10-12 Kapoor John N (Chairman of the Board) Buy 5,000 7.20 36,020
2006-10-11 Kapoor John N (Chairman of the Board) Buy 5,000 6.64 33,190
2006-10-10 Kapoor John N (Chairman of the Board) Buy 5,000 6.81 34,050
2006-10-05 Pauli Ronald (Ex. V.P. - CFO) Buy 2,000 5.60 11,198
2006-10-05 Kapoor John N (Chairman of the Board) Buy 10,000 5.58 55,820
2006-10-04 Kapoor John N (Chairman of the Board) Buy 5,000 5.46 27,325
2006-10-03 Kapoor John N (Chairman of the Board) Buy 5,000 5.57 27,845
2006-10-02 Kapoor John N (Chairman of the Board) Buy 5,000 5.38 26,885
2006-09-28 Walbert Timothy P (Ex. V.P. - Comm. Ops.) Buy 1,000 4.86 4,860
2006-09-28 Kapoor John N (Chairman of the Board) Buy 20,000 4.86 97,180
2006-09-27 Sherman Jeffrey W (Ex. VP - Chief Medical Officer) Buy 1,000 4.98 4,980
2006-09-21 Kapoor John N (Chairman of the Board) Buy 20,000 5.00 99,900
2006-08-22 Safavi Kaveh T (Director) Buy 3,882 5.04 19,561
2006-06-26 Herrera Guillermo A (President and CEO) Buy 40,000 5.00 200,000
2006-01-05 Eidell Ronald G (President and CEO) Buy 4,900 10.20 49,980
2006-01-05 Kapoor John N Buy 200,000 10.20 2,039,999
2005-09-23 Becker Frank C (Chairman) Buy 28,000 11.91 333,480
2005-03-21 Fox Bernard A (Director) Buy 600 8.59 5,154
2005-03-14 Kapoor John N Buy 68,500 8.13 556,905
2005-03-11 Eidell Ronald G (President and CEO) Buy 1,000 8.00 8,000
2005-03-11 Hanson Erick E (Chairman) Buy 2,954 8.28 24,444

Insider trading activities including stock purchases, stock sales, and option exercises of NEOL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Neopharm Inc (symbol NEOL, CIK number 942788) see the Securities and Exchange Commission (SEC) website.